ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 168 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $80 | +8.1% | 16,172 | +37.4% | 0.00% | 0.0% |
| Q4 2022 | $74 | -99.9% | 11,772 | +2.9% | 0.00% | -50.0% |
| Q3 2022 | $124,000 | -85.0% | 11,444 | -84.2% | 0.00% | -77.8% |
| Q2 2022 | $827,000 | -49.4% | 72,507 | -59.6% | 0.01% | -25.0% |
| Q1 2022 | $1,636,000 | -11.3% | 179,618 | +45.3% | 0.01% | +20.0% |
| Q4 2021 | $1,844,000 | -27.4% | 123,624 | +25.1% | 0.01% | -16.7% |
| Q3 2021 | $2,541,000 | +24.3% | 98,854 | +26.1% | 0.01% | +20.0% |
| Q2 2021 | $2,045,000 | -29.4% | 78,414 | -4.4% | 0.01% | -33.3% |
| Q1 2021 | $2,895,000 | +10.6% | 82,006 | -20.9% | 0.02% | +7.1% |
| Q4 2020 | $2,618,000 | +198.5% | 103,708 | +345.8% | 0.01% | +133.3% |
| Q3 2020 | $877,000 | -32.7% | 23,264 | -23.6% | 0.01% | -45.5% |
| Q2 2020 | $1,303,000 | +28.6% | 30,432 | -41.6% | 0.01% | +10.0% |
| Q1 2020 | $1,013,000 | +71.7% | 52,108 | +129.6% | 0.01% | +100.0% |
| Q4 2019 | $590,000 | -43.6% | 22,697 | -40.8% | 0.01% | -44.4% |
| Q3 2019 | $1,046,000 | – | 38,370 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $16,381,000 | 9.53% |
| Wildcat Capital Management, LLC | 2,128,370 | $19,389,000 | 4.96% |
| TPG GP A, LLC | 18,716,306 | $170,506,000 | 2.11% |
| Pier Capital, LLC | 746,669 | $6,802,000 | 0.87% |
| Coastal Bridge Advisors, LLC | 401,929 | $3,662,000 | 0.84% |
| HARBOR CAPITAL ADVISORS, INC. | 92,755 | $845,000 | 0.40% |
| Lombard Odier Asset Management (Switzerland) SA | 501,219 | $4,566,000 | 0.36% |
| Navalign, LLC | 74,271 | $623,000 | 0.26% |
| PDT Partners, LLC | 241,592 | $2,201,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 148,804 | $1,356,000 | 0.18% |